Paypal: Consensus Revenue Estimates Climb To $5.9 Billion For Q1

Paypal Holdings (NASDAQ: PYPL) will be reporting its first quarter financial results today after the close of markets. Analysts have a consensus $310.52 12-month price target on the company, via a total of 49 analysts, with 17 analysts having strong buy ratings. 26 analysts meanwhile have buy ratings and, six analysts have hold ratings. The street high is a $375 price target, and the lowest target sits at $175 from Seaport Global.

36 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 36 analysts is $5.9 billion; this number has been revised upwards from $5.62 billion at the start of the year. The highest revenue estimate is $6.06 billion, while the lowest is $5.8 billion.

The analyst consensus for net income for the first quarter is $1.2 billion, this is up from the start of the year which was $1.18 billion. The highest net income estimate is $1.27 billion, while the lowest is $1.17 billion.

Onto EBITDA estimates, there are currently only 15 analysts who have first-quarter EBITDA estimates. The mean is currently $1.72 billion, with this number having been revised up from $1.64 billion at the start of the year. The street high estimate currently sits at $1.89 billion in EBITDA and the lowest is $1.55 billion.

Analysts estimate that quarterly earnings per share will come in at $1.03, with this number being slightly revised up from $0.99 at the start of the year. Street high is $1.16 and the lowest estimate is $0.99 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Verano Holdings: Canaccord Reiterates $35 Price Target

On April 8th, Verano Holdings (CSE: VRNO) announced their full year 2020 and fourth quarter...

Sunday, April 11, 2021, 01:45:00 PM

Sundial: Canaccord Drops Target To $0.50 Following Q1 Results

On Monday, Sundial Growers Inc. (Nasdaq: SNDL) reported its first quarter financial results. The company...

Wednesday, May 18, 2022, 03:44:00 PM

Apple: Consensus Estimates For Q2 2021

Apple (NASDAQ: AAPL) will be reporting their fiscal second quarter on April 28th after market...

Wednesday, April 28, 2021, 11:44:00 AM

Dollarama: Canaccord Expects Same-Store Sales Growth In Q3

Dollarama (TSX: DOL) is expected to report its third quarter financial results of 2023 this...

Wednesday, December 7, 2022, 05:35:00 AM

Stifel-GMP: “White House Actions Could Catalyze A Secular Cannabis Bull Market”

Yesterday, US President Joe Biden announced that he is taking steps to make right what...

Friday, October 7, 2022, 02:18:00 PM